panax ginseng/悪性腫瘍

TECHNICAL FIELD The present invention belongs to the field of prostate cancer treatment, in particular to a traditional Chinese medicine composition for treating prostate cancer, preparation method and application thereof. BACKGROUND ART Prostate cancer (PCA) is one of the most common malignancies

CROSS-REFERENCE TO RELATED APPLICATION This application claims the benefit of Korean Patent Application No. 10-2015-0098474, filed on Jul. 10, 2015, in the Korean Intellectual Property Office, the disclosure of which is incorporated herein in its entirety by reference. BACKGROUND 1. Field One or

CROSS REFERENCE TO RELATED APPLICATIONS This application is a 35 U.S.C. .sctn. 371 National Phase Entry Application from PCT/KR2013/007852, filed on Aug. 30, 2013, and designating the United States, which is incorporated herein by reference in its entirety. TECHNICAL FIELD The present invention

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a U.S. national phase of International Application No. PCT/KR2009/006523 filed on Nov. 6, 2009, which claims the benefit of Korean Application No. 10-2008-0110086 filed on Nov. 6, 2008, the contents of which are hereby incorporated by

TECHNICAL FIELD The present invention relates to a composition containing, as an effective ingredient, an extract from the leaves and/or stems of plants belonging to Panax genus and a process for preparation of the polysaccharides, and more particularly a composition containing polysaccharides

This application claims priority upon Korean. Patent application Ser. No. KR 10-2005-00305 19 filed on Apr. 12, 2005, the contents of which are all herein incorporated by this reference in their entireties. All publications, patents, patent applications, databases and other references cited in this

FIELD OF THE INVENTION This invention relates to chemical processes of making fractions from North American ginseng (Panax quinquefolium) and compositions containing these fractions. The products of the present invention may be used to stimulate the production of antibodies, or as therapeutics

FIELD OF THE INVENTION This invention relates to chemical processes of making fractions from North American ginseng (Panax quinquefolium) and compositions containing these fractions. The products of the present invention may be used to stimulate the production of antibodies, or as therapeutics

FIELD OF THE INVENTION This invention relates to chemical processes of making fractions from North American ginseng (Panax quinquefolium) and compositions containing these fractions. The products of the present invention may be used to stimulate the production of antibodies, or as therapeutics

FIELD OF THE INVENTION This invention relates to chemical processes of making fractions from North American ginseng (Panax quinquefolium) and compositions containing these fractions. The products of the present invention may be used to stimulate the production of antibodies, or as therapeutics

TECHNICAL FIELD The invention belongs to the field of medicines, and relates to a medicine or health food for treating human cytomegalovirus infection, particularly to application of ginseng (a traditional Chinese medicine) extracts and derivatives thereof in medicines or health foods for treating

This application is the U.S. National Phase under 35 U.S.C. .sctn.371 of International Application PCT Patent Application No. PCT/KR2004/001941, filed on Aug. 2, 2004, which claims priority to Korean Patent Application No. 10-2004-055088, filed on Jul. 15, 2004, the contents of which are all herein

TECHNOLOGICAL FIELD The present invention concerns compositions having physiological activities, including but not limited to anti-tumor activity and hypoglycemic effects (i.e. blood sugar level reducing effects). More particularly, compositions are taught that comprise active ingredients found in